# Feasibility and Safety of IV Sotalol Administered as a Loading Dose to Initiate Oral Sotalol Therapy

> **NCT04473807** · PHASE4 · UNKNOWN · sponsor: **Kansas City Heart Rhythm Research Foundation** · enrollment: 80 (estimated)

## Conditions studied

- Arrhythmias, Cardiac
- Atrial Fibrillation

## Interventions

- **DRUG:** Intravenous Sotalol Administered as a Loading Dose to Initiate Oral Sotalol Therapy in Adult Patients with Atrial Fibrillation

## Key facts

- **NCT ID:** NCT04473807
- **Lead sponsor:** Kansas City Heart Rhythm Research Foundation
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-01-02
- **Primary completion:** 2022-04
- **Final completion:** 2022-06
- **Target enrollment:** 80 (ESTIMATED)
- **Last updated:** 2022-01-14

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04473807

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04473807, "Feasibility and Safety of IV Sotalol Administered as a Loading Dose to Initiate Oral Sotalol Therapy". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT04473807. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*